Conference Speakers

Nicholas Swain

CEO, Rep-L Antimicrobials, Inc.

BIOGRAPHY

•     Founder and CEO of the Bio-GENERATION® Group of Companies, commercializing material science breakthrough solutions developed in-house, including:

o     Biocidium Biopharmaceuticals – Oncology, Skin conditions, Antibiotics, Antifungals, Anti-inflammatory solutions.

o     rep-L® and bio-ARMA® - Antimicrobial platforms for numerous markets.

o     Vetacare® - Animal wound care solutions and wellness products.

o     i-SOLV® - Industrial bio-based solutions

•     8 years in pulp and paper manufacturing (Devron, Hercules, Honeywell and Measurex)

•     22 years in bio-chemistry research and development, business development, sales management.

•     7 years in Pharmaceutical development – specializing in oncology, antibiotics, antifungals and skin conditions.

•     Co-Inventor on numerous patents. Successful commercialization of many products.

---

Novel Approach to Developing Very Effective Antimicrobials

For a hundred years the development of antimicrobials either involved chemical formulations or screening of plants and plant extracts for efficacy in slowing growth or killing bacteria, fungi/molds, and other microbes to treat infected patients or provide clean, disinfected environments. A new approach is to design antimicrobials with biotechnology (bio-synthesis?), i.e. include specific biocidal properties into a biological compound/system. This has advantages in fidelity of target microbes, reducing and avoiding side-effects, and be very effective against rising threats like Candida Auris, e.g. The talk will cover briefly background of antimicrobials, the traditional and novel approach in developing them, and share successful products and versatility for adapting to new applications.